Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Boehringer’s Engelbert Tjeenk Willink leaves firm

September 28, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, Engelbert Tjeenk Willink

Boehringer Board member Engelbert Tjeenk Willink, responsible for Marketing and Sales of Prescription Medicines, has decided to leave at the …
Appointment

Two hepatitis C drugs win Prix Galien

September 28, 2012 Medical Communications, Sales and Marketing Incivo, Janssen, MSD, Victrelis, prix galien

Two new hepatitis C drugs have been given the 2012 UK Prix Galien innovative product award as joint winners in …
News

Vertex abandons hep C drug

September 27, 2012 Research and Development, Sales and Marketing Alios BioPharma, Vertex, hep C

Vertex Pharmaceutical’s pipeline has been dealt a blow with the abandonment of an investigational hepatitis C compound. The US firm, …
News

CCG warning for doctors from BMA

September 27, 2012 Sales and Marketing BMA, CCG, NHS, doctors

GPs have been urged to scrutinise the small print of the new clinical commissioning group (CCG) constitutions before they sign …
News

GlaxoSmithKline announces Board changes

September 27, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Witty

GlaxoSmithKline has announced several changes to its Board and Committee structure. The GSK Board of directors with effect from 1 …
Appointment

Trajenta added to insulin recommended in Europe

September 26, 2012 Sales and Marketing Boehringer Ingelheim, Trajenta, diabetes

The CHMP has recommended that Boehringer Ingelheim and Eli Liily and Co’s diabetes brand Trajenta should be approved as add-on …
News

Novo Nordisk to expand Beijing R&D centre

September 25, 2012 Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D

Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …
News

Pharma is recovering, says Moody’s

September 25, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Moody's, Plavix, austerity, generics, pharma

Credit ratings agency Moody’s believes that the travails of the past few years, when various big-selling drugs went off-patent, are …
News

Life Healthcare Communications appoints Lyndsey Wright

September 25, 2012 Business Services, Medical Communications, Sales and Marketing Life healthcare communications, Lyndsey Wright

Life Healthcare Communications has expanded its client services department to meet demand with the appointment of a new senior account …
Appointment

Eisai opens Fycompa UK manufacturing line

September 25, 2012 Manufacturing and Production, Sales and Marketing Eisai, Fycompa

Eisai has opened a new solid dose production line for epilepsy drug Fycompa at its UK base in Hatfield, Hertfordshire. …
News

John LaMattina: Why was bapineuzamab moved into Phase III trials?

September 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, John LaMattina, Pfizer, bapineuzamab

The recent news that the Pfizer/J&J Alzheimer’s Disease drug, bapineuzumab (bapi), had failed in critical clinical trials resulted in great …
Feature

Eliquis receives nod in AF

September 24, 2012 Sales and Marketing BMS, CHMP, Eliquis, Pfizer, Pradaxa, Xarelto

Bristol-Myers Squibb and Pfizer have received a boost with the CHMP’s recommendation that their co-marketed oral anticoagulant Eliquis should gain …
News

Amgen names Ray Jordan senior VP Corporate Affairs

September 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, J&J, JJ, Ray Jordan

Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …
Appointment

New possibility for Lilly erectile drug

September 24, 2012 Sales and Marketing CHMP, Cialis, ED, hyperplasia, lilly

Eli Lilly’s erectile disfunction (ED) brand Cialis has been recommended to treat benign prostatic hyperplasia (BPH) in Europe. If the …
News

Pharma creates non-profit R&D organisation

September 21, 2012 Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026